Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Blackledge

Showing results (81-90 of 100) with videos related to

Pageof 10
Sort By:
Cancer Chemotherapy and Pharmacology|January 1, 1986
Phase II study of ifosfamide + adriamycin in advanced soft tissue sarcoma in adults. A preliminary analysisP Dombernowsky, H Mouridsen, J Schütte, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1989
A phase II study of M-azido-pyrimethamine ethane sulphonate (MZPES) in advanced, recurrent soft tissue sarcoma. An EORTC Soft Tissue and Bone Sarcoma Group StudyG Blackledge, J Verweij, R Fuchs, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1987
Cyclophosphamide versus ifosfamide: final report of a randomized phase II trial in adult soft tissue sarcomasV H Bramwell, H T Mouridsen, A Santoro, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Cyclophosphamide versus ifosfamide: a randomized phase II trial in adult soft-tissue sarcomas. The European Organization for Research and Treatment of Cancer [EORTC], Soft Tissue and Bone Sarcoma GroupV H Bramwell, H T Mouridsen, A Santoro, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 1, 1989
The place of chemotherapy in the management of soft tissue sarcoma: experiences of the EORTC Soft Tissue and Bone Sarcoma GroupG Blackledge, A van Oosterom, H T Mouridsen, et al.
Cancer Treatment Reports|December 1, 1987
Multicenter study of trilostane: a new hormonal agent in advanced postmenopausal breast cancerC J Williams, V Barley, G Blackledge, et al.
Seminars in Oncology|February 1, 1992
Experience with ifosfamide in the EORTC Soft Tissue and Bone Sarcoma GroupG Blackledge, W P Steward, J Verweij, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Ifosfamide plus doxorubicin in previously untreated patients with advanced soft tissue sarcoma. The EORTC Soft Tissue and Bone Sarcoma GroupJ Schütte, H T Mouridsen, W Stewart, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Ifosfamide plus doxorubicin in previously untreated patients with advanced soft-tissue sarcomaJ Schütte, H T Mouridsen, W Steward, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Phase II study of nimustine in metastatic soft tissue sarcoma. European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma GroupD J Wagener, R Somers, A Santoro, et al.
Pageof 10

Showing results (81-90 of 100) with videos related to

Sort By:
Pageof 10
Cancer Chemotherapy and Pharmacology|January 1, 1986
Phase II study of ifosfamide + adriamycin in advanced soft tissue sarcoma in adults. A preliminary analysisP Dombernowsky, H Mouridsen, J Schütte, et al.
European Journal of Cancer & Clinical Oncology|December 1, 1989
A phase II study of M-azido-pyrimethamine ethane sulphonate (MZPES) in advanced, recurrent soft tissue sarcoma. An EORTC Soft Tissue and Bone Sarcoma Group StudyG Blackledge, J Verweij, R Fuchs, et al.
European Journal of Cancer & Clinical Oncology|March 1, 1987
Cyclophosphamide versus ifosfamide: final report of a randomized phase II trial in adult soft tissue sarcomasV H Bramwell, H T Mouridsen, A Santoro, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Cyclophosphamide versus ifosfamide: a randomized phase II trial in adult soft-tissue sarcomas. The European Organization for Research and Treatment of Cancer [EORTC], Soft Tissue and Bone Sarcoma GroupV H Bramwell, H T Mouridsen, A Santoro, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|November 1, 1989
The place of chemotherapy in the management of soft tissue sarcoma: experiences of the EORTC Soft Tissue and Bone Sarcoma GroupG Blackledge, A van Oosterom, H T Mouridsen, et al.
Cancer Treatment Reports|December 1, 1987
Multicenter study of trilostane: a new hormonal agent in advanced postmenopausal breast cancerC J Williams, V Barley, G Blackledge, et al.
Seminars in Oncology|February 1, 1992
Experience with ifosfamide in the EORTC Soft Tissue and Bone Sarcoma GroupG Blackledge, W P Steward, J Verweij, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1990
Ifosfamide plus doxorubicin in previously untreated patients with advanced soft tissue sarcoma. The EORTC Soft Tissue and Bone Sarcoma GroupJ Schütte, H T Mouridsen, W Stewart, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Ifosfamide plus doxorubicin in previously untreated patients with advanced soft-tissue sarcomaJ Schütte, H T Mouridsen, W Steward, et al.
European Journal of Cancer (Oxford, England : 1990)|January 1, 1991
Phase II study of nimustine in metastatic soft tissue sarcoma. European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma GroupD J Wagener, R Somers, A Santoro, et al.
Pageof 10